what is glp 1 brand name GLP-1 agonists, such as Ozempic, Wegovy, Mounjaro, and Zepbound, were originally approved by the Food and Drug Administration in 2005. They have garnered significant media attention, being referred to as both wonder GLP-1 Medications: Everything You Need

Patients taking insulin or sulfonylureas may need dose reductions of these medications to prevent hypoglycaemia as GLP-1 therapy improves glucose control

Current evidence supports a favorable safety profile in the IBD population, warranting further investigation through ongoing clinical trials

The cardiac benefits of GLP-1 agonists were not anticipated before outcome studies were performed for several reasons: (1) Historical Precedent-past experiences with other diabetes medications that unexpectedly had adverse cardiovascular effects made it less likely for researchers and clinicians to anticipate potential cardiovascular benefits without concrete evidence from large-scale trials

The evaluation costs $88 and includes: A clinical consultation with Dr